King of Prussia, PA, United States of America

Lee M Katrincic

This inventor holds 6 USPTO granted patents. Top assignees: Smithkline Beecham (Cork) Ltd, Sb Pharmco Puerto Rico Inc., Smithkline Beechman Cork Limited. Active years: 2009-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee M Katrincic. Retrieved from https://idiyas.com/inventor/lee-m-katrincic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Lee M Katrincic: Innovator in Pharmaceutical Chemistry

Introduction

Lee M Katrincic is a notable inventor based in King of Prussia, Pennsylvania. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating various medical conditions. With a total of six patents to her name, her work has had a meaningful impact on healthcare.

Latest Patents

Katrincic's latest patents focus on carvedilol phosphate salts and their corresponding compositions and methods of treatment. These inventions relate to novel crystalline forms of carvedilol dihydrogen phosphate, which is used to treat hypertension, congestive heart failure, and angina. The innovative formulations and methods she has developed are crucial for improving patient outcomes in these conditions.

Career Highlights

Throughout her career, Lee M Katrincic has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Ltd and Sb Pharmco Puerto Rico Inc. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug development.

Collaborations

Katrincic has collaborated with esteemed colleagues such as Philip C Dell'Orco and Christopher S Brook. These partnerships have fostered a collaborative environment that has led to innovative solutions in pharmaceutical research.

Conclusion

Lee M Katrincic's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a key innovator in the field. Her work continues to influence the development of effective treatments for critical health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…